Physician profile
Brad S Laudicina
NPI 1568719185
$169,895.93
in general payments reported to CMS, 2019-2025
18 companies · $100K in 2025
The $100K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2020: $326 · 2021: $364 · 2022: $318 · 2023: $13K · 2024: $55K · 2025: $100K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $129K · Travel and Lodging: $30K · Food and Beverage: $6,745 · Consulting Fee: $1,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $129,300.00 |
| Travel and Lodging | $30,064.56 |
| Food and Beverage | $6,745.10 |
| Consulting Fee | $1,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $167,583.95 | 2022-2025 | Infuse, Infuse Multifocal, Scoutpro Osmolarity System |
| Alcon Vision LLC | $482.84 | 2019-2025 | Total30, Eysuvis, Precision7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $348.37 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $192.66 | 2019-2021 | |
| Sight Sciences, INC. | $150.00 | 2022 | |
| Rxsight INC | $136.36 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Maculogix, INC. | $131.19 | 2020 | |
| Amgen INC. | $121.85 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $109.28 | 2024 | Tecnis Iol |
| Glaukos Corporation | $106.97 | 2025 | Kxl System (Not Refurbished) |
| Lombart Brothers, INC. | $92.71 | 2020 | |
| Optovue, INC. | $92.59 | 2019 | |
| Coopervision INC. | $90.20 | 2019-2024 | Misight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $80.58 | 2025 | Xdemvy |
| Visioneering Technologies, INC. | $75.20 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Samsara Vision | $63.91 | 2022 | |
| Harrow Eye, LLC | $20.15 | 2024 | Vevye |
| Johnson & Johnson Vision Care, INC. | $17.12 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Laudicina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.